Strength
50 mg/1
Manufacturer
AvPAKNDC
50268076915
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077670On Market Since
2/6/2024
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE HCL 50 MG TABLET has been published 107 times since Jun 12, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0343 per EA |
|---|---|
| All-time high | $0.0396 (Nov 13, 2024) |
| All-time low | $0.0292 (Nov 20, 2024) |
| 52-week high | $0.0388 |
| 52-week low | $0.0343 |
| Median price | $0.0362 |
| Average price | $0.0361 |
| Largest weekly change | -26.1% (Nov 20, 2024) |
| Weeks tracked | 107 |
| Tracking since | Jun 12, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SERTRALINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE HCL 50 MG TABLET, manufactured by AvPAK, is $0.0343 per EA (NDC 50268076915), effective Jun 24, 2026.
How has the price of SERTRALINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for SERTRALINE HCL 50 MG TABLET has held within roughly two percent of its current level. It has been tracked across 107 weekly CMS publications since Jun 12, 2024.
What are the highest and lowest recorded NADAC prices for SERTRALINE HCL 50 MG TABLET?
Since Jun 12, 2024, the NADAC for SERTRALINE HCL 50 MG TABLET has ranged from a low of $0.0292 (Nov 20, 2024) to a high of $0.0396 (Nov 13, 2024), with a median of $0.0362 per EA.
Are there cheaper alternatives to SERTRALINE HCL 50 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as SERTRALINE HCL 50 MG TABLET, but none are currently priced below it.
Who manufactures SERTRALINE HCL 50 MG TABLET?
SERTRALINE HCL 50 MG TABLET (NDC 50268076915) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification